The OIE has developed a new concept of Vaccine Bank which creates virtual rolling stocks: the supplier (selected OIE compliant vaccine production company) produces the vaccines when needed or they remain with the supplier at its own risk and are renewed on a rolling basis under terms and conditions contractually defined with the OIE. This revised concept enables the rapid supply of emergency stock of vaccines to infected countries in order to vaccinate animal populations at risk and to progressively achieve eradication wherever possible.
In 2006, the OIE set up a Regional Vaccine bank for Avian Influenza vaccines in Africa funded under the European Union Pan African Programme for the Control of Epizootics (PACE) and in 2007 also established a global vaccine bank for Avian Influenza vaccines funded by Canada (Canadian International Development Agency).
Through these two programs, a total of 62,017 million H5N2 doses were delivered to the following countries: Mauritania, Senegal, Egypt, Mauritius, Ghana, Togo and Vietnam. Egypt and Vietnam accounted for the most significant levels of distribution, with approximately 28 million and 26.7 million doses respectively (including timely vaccine delivery from the United Kingdom and Canada). At present, the Avian Influenza vaccine bank is empty.
The European Union funded Regional Cooperation Programme on Highly Pathogenic Emerging and Re-emerging animal diseases (HPED) will see the expansion of the Vaccine Bank to Asia and will be able to rapidly provide eligible countries with an emergency stock of vaccines to vaccinate animal populations at risk under the framework of agreed vaccination strategies.
In addition to the 40% of this budget allocated to Avian Influenza, the vaccine bank will also target foot and mouth disease, rabies and possibly other pathogenic emerging and re-emerging transboundary diseases. The vaccines reserved for foot and mouth disease will represent 30% of the budget and will be used for strategic vaccination in buffer zones (ring vaccination)/ hot spots around disease-free areas in order to stop the spread of the disease but to also reduce the associated economic costs caused by the loss of FMD free status.
20% of the vaccine bank budget has been earmarked for the oral immunization campaigns of stray dogs against rabies. The elimination of rabies is both a public health and economic priority and hence eradicating the spread of this zoonotic disease is essential in order to reduce the socio-economic cost of post contamination treatment of humans.
The remaining 10% of the budget will be considered as a reserve for “other vaccines” for non-identified highly pathogenic emerging and re-emerging animal diseases. The banking of vaccines for an array of diseases signifies an important development to counter the spread of transboundary animal diseases globally.
The OIE International Call for Tender for the establishment of a "PPR Vaccine Bank in Africa" has been launched and is available for download here. Tenders must be received at the OIE Headquarters by Monday, 3 December 2012 at 15:00 (Paris time).